Europe considers relaxing DTP law

Share this article:

European Union regulators are weighing relaxing a prohibition on direct communication with patients by drug companies. 

European Medicines Agency head Peter Arlett told Bloomberg the European Commission “will revise the proposals to clarify and harmonize the rules in what companies can and can't say to patients.”

There has long been talk of liberalization of consumer promotion regs in Europe, though US-style ads are not in the cards. However, regulators have in the past indicated openness to letting drug makers put more information online and communicate with patients through opt-in direct mail and emails.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?